To uncover underlying mechanisms of the therapeutic effect of anti-VEGF-B and anti-IL-17A in DKD mice, the transcriptomic changes of mice renal tissues were measured using RNA-seq. This evidence concerns the gene VEGFB and diabetic kidney disease.